
About WhiteLab Genomics
WhiteLab Genomics is a Healthcare company based in Paris (France) founded in 2019 by Julien Cottineau and David Del Bourgo. AI platform for drug discovery and development is provided. WhiteLab Genomics has raised $36.24 million across 4 funding rounds from investors including Debiopharm, EIT Health and Omnes Capital. Its chief executive, as recorded, is David Del Bourgo. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.
Company details
WhiteLab Genomics was founded in 2019 and is based in Paris, France. Operations focus on the biotechnology sector, where an AI-driven platform is utilized to predict and identify potential drug candidate molecules. This technology supports therapeutic development by analyzing molecular data for pharmaceutical applications. Services are directed toward enhancing efficiency in drug discovery processes for research entities.
- Headquarters Paris, France
- Founders Julien Cottineau, David Del Bourgo
- SectorsHealthcare
- Email••••••••
- Website whitelabgx.com
- Social LinkedIn X
- Total Equity Funding$36.24M (USD)
in 4 rounds
- Latest Funding Round$26M (USD), Series B
Oct 2026
- InvestorsDebiopharm
& 4 more
Funding Insights of WhiteLab Genomics
WhiteLab Genomics has successfully raised a total of $36.24M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $26 million completed in October 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $36.24M
- Total Rounds 4
- Last Round Series B — $26M
- First Round $44,800
(Jul 2019)
- Investors Count 5
All 4 funding rounds of WhiteLab Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2026 | $26M | Series B | – | – | |
| Sep 2022 | $10.12M | Series A | – | Debiopharm, Omnes Capital | – |
| Jun 2022 | $125,000 | Seed | – | Y Combinator | – |
| Jul 2019 | $44,800 | Grant | – | – |
5 investors in total: 5 institutional.
Investors in WhiteLab Genomics
WhiteLab Genomics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Debiopharm, EIT Health and Omnes Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on energy transition and sustainable investments across Europe. | omnescapital.com | |||
Early-stage startups are accelerated via funding and educational programs. | ycombinator.com | Mountain View, United States | ||
Healthcare startups are accelerated and incubated through specialized programs. | 2015 | eithealth.eu | Munich, Germany | |
Biopharmaceutical company focused on oncology, infectious diseases, and orphan drugs | 1979 | debiopharm.com | Lausanne, Switzerland | |
| blast.club |
Investor details for WhiteLab Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of WhiteLab Genomics
15 people are tracked at WhiteLab Genomics (7 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Julien Cottineau | Co-Founder & CSO | Leadership |
David Del Bourgo | Co-Founder & CEO | Leadership |
Lucia Cinque | Co-founder & Chief Of Staff | Leadership |
Dina Zielinski | Head Of Computational Biology | Leadership |
Dylan SERILLON | Head Of Protein & Vector Engineering | Leadership |
Domitille Halie | Head Of Scientific Project Management | Leadership |
Maud Thouverez | Head Of People And Culture | Leadership |
Abiramy Sinnadurai | Marketing | Team |
Lélia Polit | Computational Biologist | Team |
Perla El Darazi | Scientific Project Manager | Team |
Morgane Colléaux-Royer | Product Manager | Team |
Xi Liu | Senior Computational Biologist | Team |
Xie Ting | Senior Bioinformatician | Team |
Yanis Habtoun | Informaticien De La Recherche Scientifique | Team |
Camille Alliot | Biologiste Structuraliste | Team |
Complete people profiles for WhiteLab Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of WhiteLab Genomics
3 dated milestones of WhiteLab Genomics across 7 years, from founding to its latest funding, stage changes and deals.
- Founded WhiteLab Genomics is founded.
- Funding First funding round of $45K.
- Funding Latest funding round, Series B, of $26.0M.
Web traffic of WhiteLab Genomics
The website of WhiteLab Genomics (whitelabgx.com) receives about 6.1K visits a month.
- Monthly visits6.1K
▲ 31.9% vs previous month
Websites whose visitors overlap most with WhiteLab Genomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| basepairtech.com | 100% | 13.3K | #1,123,186 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Whitelab Genomics
Complete news archive for WhiteLab Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about WhiteLab Genomics
WhiteLab Genomics was founded in 2019.
WhiteLab Genomics is headquartered in Paris, France.
David Del Bourgo is the CEO of WhiteLab Genomics, as recorded in our data. They have also founded this company.
WhiteLab Genomics is a funded company, having raised a total of $36.24M across 4 funding rounds to date. The company's 1st funding round was a Grant of $44.8K, raised on Jul 2019.
WhiteLab Genomics was founded in 2019 and is based in Paris, France. Operations focus on the biotechnology sector, where an AI-driven platform is utilized to predict and identify potential drug candidate molecules. This technology supports therapeutic development by analyzing molecular data for pharmaceutical applications. Services are directed toward enhancing efficiency in drug discovery processes for research entities.
WhiteLab Genomics has 5 investors. Key investors include Debiopharm, EIT Health, Omnes Capital, Y Combinator, and Blast Club.
